Author

Chih-Sung Liang

Observed name: Liang, Chih-Sung

Institutions: Tri-Service General Hospital, Chang Gung University, Tri-Service General Hospital Beitou Branch, National Defense Medical Center

Observed institutions: Tri-Service General Hospital, Chang Gung University, Tri-Service General Hospital Beitou Branch, National Defense Medical Center

ORCID: 0000-0003-1138-5586

Observed ORCID: 0000-0003-1138-5586

OpenAlex ID: A5120940974

Agent- and Dose-Specific Intestinal Obstruction Safety of GLP-1 Receptor Agonists and SGLT2 Inhibitors: A Network Meta-Analysis of Randomized Trials

2026 · Jiann-Jy Chen, Chih-Wei Hsu, et al. · International Journal of Molecular Sciences · 6

Comparison of rTMS and esketamine for treatment-resistant depression: A target trial emulation

2026 · Jen-Ping Chen, Chih-Wei Hsu, et al. · Journal of Affective Disorders · 1

Additional file 1 of Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants

2026 · Lin, Pao-Yen, Zeng, Bing-Syuan, et al. · Figshare

Predicting five-year comorbid bipolar disorder after attention-deficit/hyperactivity disorder diagnosis: a population-based machine learning approach

2026 · Yang, Yen-Shan, Hsu, Chih-Wei, et al. · Figshare

The evidence gap of lithium, triiodothyronine, buspirone augmentation for major depression: a trial sequential analysis

2025 · Liang, Chih-Sung · OSF Preprints (OSF Preprints)

Works count: 6

Citation count: 7

H-index: 1

I10-index: